Company profile: Nano Precision Medical
1.1 - Company Overview
Company description
- Provider of miniaturized subdermal implants using the NanoPortal membrane to deliver steady, long-term therapeutics for chronic diseases. Offerings include the NanoPortal Platform Technology; NPM-115 for chronic weight management and NPM-119 for type 2 diabetes, each designed to provide steady medication for up to six months; and Cortigent neurostimulation systems for artificial vision and muscle movement restoration.
Products and services
- NanoPortal Platform Technology: Proprietary platform featuring the NanoPortal membrane that engineers steady, long-term medication delivery to improve tolerability and ensure consistent dosing over extended periods
- NPM-119: Miniaturized subdermal implant delivering exenatide for type 2 diabetes, architected to maintain steady medication for up to six months
- NPM-115: Subdermal implant delivering high-dose exenatide for chronic weight management, engineered to sustain steady medication for up to six months
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nano Precision Medical
Corsair Pharma
HQ: United States
Website
- Description: Provider of a transdermal treprostinil prodrug patch for pulmonary arterial hypertension (PAH), designed to deliver consistent blood levels and reduce the need for invasive administration. Develops transformative solutions to improve the therapeutic profile of medications and provide superior treatment for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corsair Pharma company profile →
Biora Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology as a biotech company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biora Therapeutics company profile →
TriSalus
HQ: United States
Website
- Description: Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriSalus company profile →
CeQur
HQ: Switzerland
Website
- Description: Provider of wearable insulin delivery solutions for people with diabetes, including the CeQur Simplicity insulin patch that delivers mealtime bolus insulin via a small, flexible cannula without injections. Offers a Patient Starter Kit with patches and a reusable inserter, the CeQur Cares support program, and the CeQur Simplicity Copay Savings Card. Works with physicians and centers to bring technology to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeQur company profile →
BlueWillow Biologics
HQ: United States
Website
- Description: Provider of intranasal vaccine and adjuvant technologies, including an oil-in-water emulsion Intranasal Adjuvant Technology, NE01 adjuvanted intranasal vaccines, the BW-1010 anthrax vaccine candidate, and a therapeutic peanut allergy vaccine, built on the NanoVax platform to elicit mucosal, cellular, and systemic immunity; also focused on topical antiseptic and anti-infective products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlueWillow Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nano Precision Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nano Precision Medical
2.2 - Growth funds investing in similar companies to Nano Precision Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nano Precision Medical
4.2 - Public trading comparable groups for Nano Precision Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →